Virginia Retirement Systems’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$911K Sell
18,336
-9,900
-35% -$481K 0.01% 618
2025
Q3
$1.35M Sell
28,236
-20,500
-42% -$826K 0.01% 504
2025
Q2
$1.54M Buy
48,736
+19,000
+64% +$609K 0.01% 461
2025
Q1
$974K Buy
+29,736
New +$1.05M 0.01% 563
2023
Q3
$562K Buy
20,400
+2,000
+11% +$60.9K 0.01% 661
2023
Q2
$553K Buy
+18,400
New +$644K 0.01% 700
2022
Q1
Sell
-12,600
Closed -$367 1212
2021
Q4
$367 Sell
12,600
-10,700
-46% -$325K ﹤0.01% 937
2021
Q3
$621K Sell
23,300
-5,500
-19% -$148K 0.01% 755
2021
Q2
$887K Sell
28,800
-2,300
-7% -$70.5K 0.01% 688
2021
Q1
$814K Sell
31,100
-4,200
-12% -$117K 0.01% 725
2020
Q4
$888K Sell
35,300
-4,000
-10% -$86.1K 0.01% 643
2020
Q3
$819K Sell
39,300
-1,300
-3% -$29.5K 0.01% 598
2020
Q2
$964K Sell
40,600
-3,900
-9% -$86.2K 0.01% 572
2020
Q1
$801K Hold
44,500
0.01% 629
2019
Q4
$1.06M Buy
44,500
+100
+0.2% +$2.43K 0.01% 669
2019
Q3
$1.22M Buy
44,400
+18,700
+73% +$554K 0.01% 605
2019
Q2
$850K Sell
25,700
-8,400
-25% -$288K 0.01% 725
2019
Q1
$1.2M Buy
34,100
+1,600
+5% +$59.5K 0.01% 607
2018
Q4
$1.08M Buy
32,500
+16,000
+97% +$688K 0.01% 593
2018
Q3
$831K Sell
16,500
-6,300
-28% -$311K 0.01% 767
2018
Q2
$1.36M Sell
22,800
-6,900
-23% -$357K 0.02% 577
2018
Q1
$1.36M Sell
29,700
-17,000
-36% -$709K 0.02% 557
2017
Q4
$1.86M Sell
46,700
-5,300
-10% -$209K 0.02% 493
2017
Q3
$2.08M Sell
52,000
-16,200
-24% -$701K 0.03% 489
2017
Q2
$2.94M Sell
68,200
-3,600
-5% -$128K 0.04% 378
2017
Q1
$2.25M Buy
71,800
+10,500
+17% +$281K 0.03% 445
2016
Q4
$1.55M Buy
61,300
+4,300
+8% +$96.1K 0.02% 471
2016
Q3
$1.41M Buy
57,000
+45,500
+396% +$1.03M 0.02% 474
2016
Q2
$234K Buy
+11,500
New +$204K ﹤0.01% 875

Other funds holding SUPN